BVF INC/IL - Q1 2017 holdings

$588 Million is the total value of BVF INC/IL's 30 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .

 Value Shares↓ Weighting
ANAB NewANAPTYSBIO INC$48,246,0001,738,600
+100.0%
8.21%
CTIC NewCTI BIOPHARMA CORP$18,815,0004,479,691
+100.0%
3.20%
BLRX NewBIOLINERX LTD SPONSOREDsponsored adr$16,809,00017,500,000
+100.0%
2.86%
LOXO NewLOXO ONCOLOGY INC$13,466,000320,000
+100.0%
2.29%
RGLS NewREGULUS THERAPEUTICS INC$1,028,000623,000
+100.0%
0.18%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XENON PHARMACEUTICALS INC36Q3 20234.7%
PIERIS PHARMACEUTICALS INC30Q3 20232.8%
CYTOKINETICS INC29Q4 202011.8%
INFINITY PHARMACEUTICALS INC29Q2 20234.3%
XOMA CORP DEL28Q3 20237.3%
ARQULE INC27Q4 20194.8%
CHEMOCENTRYX INC26Q3 201913.8%
CYTOMX THERAPEUTICS INC26Q3 20235.3%
CORVUS PHARMACEUTICALS INC26Q3 20232.3%
ARRAY BIOPHARMA INC25Q2 201914.5%

View BVF INC/IL's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-01-29
32024-01-26
42024-01-09
42023-12-20
42023-11-17
13F-HR2023-11-14
32023-11-13
32023-11-06
42023-11-06

View BVF INC/IL's complete filings history.

Compare quarters

Export BVF INC/IL's holdings